To allow all authors an opportunity to experience this exciting new offering, APS is waiving open access article-processing charges (APCs) for all …
Check Also
Rebuttal To A Bearish Article About Amarin
Confusion remains about Amarin’s blockbuster trial results for its cardiovascular protection drug, Vascepa. A recent …